Evidence map›Paper›PMID 19242372›Full record

ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2009

CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination.

Yael Goldfarb, Marganit Benish, Ella Rosenne, Rivka Melamed, Ben Levi, Ariella Glasner, Shamgar Ben-Eliyahu

Open access · greenAbstract read
In one paragraph

Article in Journal of immunotherapy (Hagerstown, Md. : 1997), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yael GoldfarbDepartment of Psychology, Neuroimmunology Research Unit, Tel-Aviv University, Tel-Aviv, Israel.
Marganit Benish
Ella Rosenne
Rivka Melamed
Ben Levi
Ariella Glasner
Shamgar Ben-Eliyahu
Tel Aviv University · IL

Funding

Psychoneuroimmunology-Immunotherapy interactionsR01CA125456 · NCI · TEL AVIV UNIVERSITY · PI BEN-ELIYAHU, SHAMGAR · 2007 to 2011
$929k
NCI NIH HHS CA125456NCI NIH HHS R01 CA125456
6 · The paper itself

Abstract

Suppression of natural killer (NK) cell activity is common after stress, has been reported to predict malignant recurrence in cancer patients, and was shown to underlie metastatic dissemination in animal models. We have previously reported that catecholamines play a major role in NK cell suppression, particularly in the context of physiologic stress and surgery. In the current study using Fisher 344 rats, we examined the prophylactic use of different regimens of type-C CpG oligodeoxynucleotides (CpG-C ODN) on NK activity and metastatic dissemination in the context of pharmacologic stress (using metaproterenol for beta-adrenoceptor stimulation). Our results indicated that the beneficial effects of CpG-C ODN were more profound under pharmacologic stress than under baseline conditions. A bolus of CpG-C ODN (330 microg/kg, intraperitoneally) 24 hours before metaproterenol-challenge was most effective at reducing lung tumor retention of an experimental syngeneic mammary adenocarcinoma (MADB106), although having no observable side effects. Depletion of NK cells revealed their key role in improving baseline levels of resistance to metastatic dissemination after CpG-C ODN administration. When NK cell cytotoxicity was assessed in the circulation and the marginating-pulmonary immune compartments, we found that CpG-C ODN protected individual NK cells from metaproterenol-induced suppression in both compartments. Moreover, in the critical marginating-pulmonary compartment, CpG-C ODN also elevated baseline cytotoxicity per NK cell against MADB106 tumor cells, and increased NK cell numbers in nonstressed rats. Overall, prophylactic CpG-C ODN treatment can improve immunocompetence and potentially reduce metastatic dissemination, especially in clinical settings characterized by enhanced sympathetic stress responses.

Indexed as

Adjuvants, ImmunologicAnimalsCell Line, TumorCytotoxicity, ImmunologicImmunosuppression TherapyKiller Cells, NaturalMammary Neoplasms, AnimalMetaproterenolNeoplasm MetastasisOligodeoxyribonucleotidesRatsRats, Inbred F344Receptors, Adrenergic, betaAdjuvants, ImmunologicCPG-oligonucleotideMetaproterenolOligodeoxyribonucleotidesReceptors, Adrenergic, beta

Identifiers

PMID19242372
PMCPMC2738855
OpenAlexW2079591564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.